Enhabit Inc (EHAB) FinancialsEHABEnhabit Inc

Enhabit Inc (EHAB) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Home health, accounting for 76.2% of total sales, equivalent to $201.80M. Another important revenue stream is Hospice. Understanding this composition is critical for investors evaluating how EHAB navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Enhabit Inc maintains a gross margin of 47.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.42%, while the net margin is 7.52%. These profitability ratios, combined with a Return on Equity (ROE) of -0.58%, provide a clear picture of how effectively EHAB converts its operational activities into shareholder value.

In the context of the broader market, EHAB competes directly with industry leaders such as LMRI and AZTA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, EHAB's gross margin of 47.58% stands against LMRI's 10.90% and AZTA's 44.89%. Such benchmarking helps identify whether Enhabit Inc is trading at a premium or discount relative to its financial performance.